These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Tissue factor pathway inhibitor-2 is downregulated by ox-LDL and inhibits ox-LDL induced vascular smooth muscle cells proliferation and migration. Zhao B; Luo X; Shi H; Ma D Thromb Res; 2011 Aug; 128(2):179-85. PubMed ID: 21458846 [TBL] [Abstract][Full Text] [Related]
6. Expression of serine proteinase inhibitor PP5/TFPI-2/MSPI decreases the invasive potential of human choriocarcinoma cells in vitro and in vivo. Jin M; Udagawa K; Miyagi E; Nakazawa T; Hirahara F; Yasumitsu H; Miyazaki K; Nagashima Y; Aoki I; Miyagi Y Gynecol Oncol; 2001 Nov; 83(2):325-33. PubMed ID: 11606093 [TBL] [Abstract][Full Text] [Related]
7. Suppression of invasion and MMP-9 expression in NIH 3T3 and v-H-Ras 3T3 fibroblasts by lovastatin through inhibition of ras isoprenylation. Wang IK; Lin-Shiau SY; Lin JK Oncology; 2000 Sep; 59(3):245-54. PubMed ID: 11053993 [TBL] [Abstract][Full Text] [Related]
8. R-Ras promotes tumor growth of cervical epithelial cells. Rincón-Arano H; Rosales R; Mora N; Rodriguez-Castañeda A; Rosales C Cancer; 2003 Feb; 97(3):575-85. PubMed ID: 12548599 [TBL] [Abstract][Full Text] [Related]
13. Cyclic AMP-regulated synthesis of the tissue inhibitors of metalloproteinases suppresses the invasive potential of the human fibrosarcoma cell line HT1080. Tanaka K; Iwamoto Y; Ito Y; Ishibashi T; Nakabeppu Y; Sekiguchi M; Sugioka Y Cancer Res; 1995 Jul; 55(13):2927-35. PubMed ID: 7796421 [TBL] [Abstract][Full Text] [Related]
14. Human tissue factor pathway inhibitor-2 does not bind or inhibit activated matrix metalloproteinase-1. Du X; Chand HS; Kisiel W Biochim Biophys Acta; 2003 Jun; 1621(3):242-5. PubMed ID: 12787920 [TBL] [Abstract][Full Text] [Related]
16. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells. Su ZZ; Austin VN; Zimmer SG; Fisher PB Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744 [TBL] [Abstract][Full Text] [Related]
17. Oncogenes and Angiogenesis: down-regulation of thrombospondin-1 in normal fibroblasts exposed to factors from cancer cells harboring mutant ras. Kalas W; Yu JL; Milsom C; Rosenfeld J; Benezra R; Bornstein P; Rak J Cancer Res; 2005 Oct; 65(19):8878-86. PubMed ID: 16204059 [TBL] [Abstract][Full Text] [Related]
18. Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2. Rao CN; Reddy P; Liu Y; O'Toole E; Reeder D; Foster DC; Kisiel W; Woodley DT Arch Biochem Biophys; 1996 Nov; 335(1):82-92. PubMed ID: 8914837 [TBL] [Abstract][Full Text] [Related]
19. Transient alterations in the expression of protease and extracellular matrix genes during metastatic lung colonization by H-ras-transformed 10T1/2 fibroblasts. Gingras MC; Jarolim L; Finch J; Bowden GT; Wright JA; Greenberg AH Cancer Res; 1990 Jul; 50(13):4061-6. PubMed ID: 2191771 [TBL] [Abstract][Full Text] [Related]
20. Subtraction cloning of H-rev107, a gene specifically expressed in H-ras resistant fibroblasts. Hajnal A; Klemenz R; Schäfer R Oncogene; 1994 Feb; 9(2):479-90. PubMed ID: 8290259 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]